This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In an interview, Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, professor of practice, sciences, and health outcomes research at the University of Maryland, explored the evolving landscape of vaccine recommendations, emphasizing the critical role pharmacists play in guiding patients through complex medical information.
In 2022, the Advisory Committee on Immunization Practices (ACIP) published updated pneumococcal vaccine recommendations. In 2022, the Advisory Committee on Immunization Practices (ACIP) published updated pneumococcal vaccine recommendations. Of those, 38% had evidence of pneumococcal vaccination prior to January 2022.
In an interview on vaccine recommendations, health care professionals expressed growing concerns about the changing landscape of medical information dissemination. Health care professionals emphasize patient education and reliable information in the evolving vaccine recommendation landscape.
Garofoli, PharmD, BCACP, CTTS, FAPhA Publication Article Drug Topics Journal Drug Topics May/June 2025 Volume 169 Issue 03 Pharmacy team members can help patients prepare for upcoming travels, ensuring they are up to date with the recommended vaccines for their locations. The first resource is the CDC’s Yellow Book.
Experts discuss the recent dismissal of all 17 members of the Advisory Committee on Immunization Practices (ACIP), a panel that provides guidance to the CDC on vaccine recommendations. This abrupt change has raised significant concerns within the health care community about the potential impact on vaccine trust and public health policy.
The shift away from thimerosal may increase the use of single-dose syringes, impacting vaccination practices in various healthcare settings. The shift away from thimerosal may increase the use of single-dose syringes, impacting vaccination practices in various healthcare settings.
Parental vaccine hesitancy, fueled by misinformation and logistical barriers, contributes to lower immunization rates and increased exemption rates. Pharmacies enhance vaccine access and education, offering convenient vaccination opportunities and personalized counseling to counter hesitancy.
Expanding use of the 15-valent pneumococcal conjugate vaccine (PCV15) or 20-valent pneumococcal conjugate vaccine (PCV20) to all United States adults aged 50 to 64 years would result in modest budget increases over a 3-year period.
Increased awareness of infectious diseases during the pandemic may have improved vaccine uptake among Medicare enrollees, while service reductions and vaccine hesitancy affected Medicaid enrollees.
The FDA has approved a prefilled syringe format of the recombinant zoster vaccine Shingrix for the prevention of shingles, GSK said in a release. 1 The company said approval of the new presentation was based on data that showed comparability between the new and existing version of the vaccine.
The updated COVID-19 mRNA vaccine that contained the Omicron JN.1 Investigators analyzed 29 AEs of special interest for COVID-19 vaccinations. 1 The 2024-2025 updated COVID-19 vaccine containing the Omicron JN.1 1 booster vaccination. . 1 booster vaccination. years, were included. for myocarditis.
References FDA. Updated July 31, 2025. FDA Approves the First 3D Printed Product. Triastek's 3D-Printed Gastric Retention Product T20G Receives FDA IND Clearance. March 17, 2025. March 21, 2025. International Journal of Pharmaceutics , 2025 Volume 676, 125581. Ema.europa.eu. Press Release.
Needle of a syringe protrudes through the rubber cap of a vaccine vial with red cap. SHOW MORE Thermoplastic elastomers (TPE) offer a PFAS-free solution for stoppers in parenteral packaging, ensuring a safer and more sustainable product.
Once the 351 Rite Aid pharmacies in Pennsylvania finally close in 2025, that will be over 600 pharmacies in Pennsylvania that closed in the last 2 years. Reimbursements are a lot better in vaccines than it is in just filling scripts. That is a real problem. We are now at the tipping point, if not beyond the tipping point.
Experts Debate Diabetes Care in Community Pharmacy vs Health Systems Despite evidence of improved diabetes outcomes, all pharmacy settings are capable of having a significant impact on diabetes care, according to a presentation at the American Pharmacists Association (APhA) 2025 Annual Meeting and Exposition.
RSV vaccines are recommended for older adults and those with specific health conditions, with options like Arexvy, mResvia, and Abrysvo available. RSV vaccines are recommended for older adults and those with specific health conditions, with options like Arexvy, mResvia, and Abrysvo available.
The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, showcased significant advances across a range of malignancies, with novel agents, biomarker-driven strategies, and long-term outcomes data offering new insights into cancer treatment with implications for pharmacy practice.
In a vote of 5 to 1 on Thursday, members of the Advisory Committee on Immunization Practices (ACIP) voted to recommend against influenza vaccine containing the preservative thimerosal. The recommendations include all US adults as well as recommending pregnant women also receive a thimerosal-free vaccine for influenza.
Soefje, PharmD, MBA, BCOP, FCCP, FHOPA Scott Soefje, PharmD, MBA, BCOP, shares insights about the evolving role of pharmacists at the 2025 OPC meeting. Pharmacy Times : Can you share an overview of what you discussed at OPC 2025? Author(s): Alexandra Gerlach, Associate Editor , Scott A.
Finerenone and the Future of Diabetes-Related Kidney Care Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now!
1 READ MORE: Infections for Measles, Bird Flu, and Pertussis Increase in 2025 In China, where AMR is also on the rise, their systems for facilitating ASPs are complex and create difficulty for pharmacists and other providers to provide care. 2025 Jul 28;18:3735-3744. Accessed August 8, 2025. February 4, 2025.
Laura Stiles also reports on current influenza vaccination updates following changes to the Advisory Committee on Immunization Practices, as well as updates to influenza vaccination requirements.
2025; [link] 2. Accessed July 17, 2025. Accessed July 17, 2025. Dupilumab Shows Superiority Over Omalizumab for Chronic Rhinosinusitis Ashley Gallagher June 16th 2025 Article This study is the first to compare 2 biologics for patients with chronic rhinosinusitis with nasal polyps and coexisting asthma. Med Princ Pract.
Pharmacy Technicians Could Enhance Public Health by Becoming ‘Vaccine Champions’ Killian Meara October 3rd 2024 Article Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates.
The FDA approved delgocitinib (Anzupgo) cream for the treatment of moderate-to-severe chronic hand eczema (CHE) in adult patients, LEO Pharma announced in a release. 1 “We’re thrilled that the FDA recognizes the impact that moderate-to-severe [CHE] has on patients,” said Kristin Belleson, CEO and president of the National Eczema Association.
Check out our full report below: Apellis Pharmaceuticals and Sobi Report P-III (VALIANT) Trial Data of Empaveli for C3 Glomerulopathy (C3G) and Primary IC-MPGN Read More: Apellis Pharmaceuticals and Sobi Daiichi Sankyo Reports First Patient Dosing in P-III (DESTINY-Endometrial01) Study Evaluating ENHERTU Read More: Daiichi Sankyo Regeneron Highlights (..)
Building trust and relationships with community partners is essential for effective vaccine advocacy and outreach. Offering education, mobile clinics, and convenient access to vaccines can address barriers and improve vaccination rates.
The Current State Of OTC Medication Use for Pain Management Brian Nowosielski ; Mark Garofoli, PharmD, BCGP, CPE, CTTS April 24th 2025 Podcast Leveraging his expertise in pain management, Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, joined Drug Topics to discuss the importance of pharmacists in patients’ use of OTC medications to treat pain.
McKesson ideaShare 2025 brought thousands of independent pharmacists, pharmacy owners, technicians, and industry leaders together in Nashville, Tennessee, shining a spotlight on innovation and advocacy in community pharmacy. SHOW MORE Dave’s Pharmacy in Alliance, Nebraska, was named the Pharmacy of the Year for cutting-edge patient care.
The FDA has approved vancomycin injection, USP (Tyzavan; Hikma Pharmaceuticals PLC), for the treatment of septicemia, infective endocarditis, skin and skin structure infections, bone infections, and lower respiratory tract infections in adult and pediatric patients 1 month and older for whom appropriate dosing can be achieved.
June 17, 2025. Accessed June 18, 2025. Accessed June 18, 2025. Accessed June 18, 2025. Published online June 6, 2025. The Hospital For Sick Children. Type 1 diabetes. October 18, 2016. Adolescent Type 1 Diabetes Treatment With SGLT2i for hyperglycEMia & hyPerfilTration Trial (ATTEMPT).
Accessed July 23, 2025. January 14, 2025. Accessed July 23, 2025. Accessed July 23, 2025. link] To Prohibit a Pharmacy Benefits Manager from Obtaining Certain Pharmacy Permits (AK HB1150); 2025. Here’s How. April 9, 2024. link] FTC Releases Second Interim Staff Report on Prescription Drug Middlemen. News release.
SHOW MORE The FDA intends to update opioid labels to highlight risks of addiction, overdose, and interactions, enhancing safety in pain management practices. Pharmacists are pivotal in educating patients, verifying prescriptions, and collaborating with prescribers to ensure safe opioid management and reduce harm.
Pharmacy Times : Can you share your experience at OPC 2025 and the significance of these meetings for pharmacists? It’s been a great partnership and collaboration with HOPA, and I’d like to think it helps elevate both of us—delivering cutting-edge, nimble, and important information to the field.
Historically, the FDA has required preclinical testing in animals to obtain safety and efficacy data for investigational new drugs (INDs) before they can begin clinical testing in humans. 3 More simply, the FDA is moving preclinical testing from in vivo animal models to in silico and in vitro methods.
In an interview with Pharmacy Times® , Gabe Hinojosa, PharmD, BCOP, clinical pharmacy specialist oncology/hematology at UT Southwestern, discussed the evolving treatment landscape for multiple myeloma (MM) and presented data from the 2025 American Society of Clinical Oncology Annual Meeting (ASCO).
Grillo, MBA, RPh Key Takeaways Vaccination has saved millions of lives, yet vaccine hesitancy remains a significant global health threat, fueled by misinformation and systemic barriers.
At McKesson ideaShare 2025, pharmacy leaders spotlighted the growing role of pharmacists in expanding clinical services, including telehealth, contraception prescribing, naloxone access, and point-of-care testing (POCT). SHOW MORE Pharmacy-based clinical services demonstrate both public health impact and financial sustainability.
These deserts reduce access to critical health care services, such as vaccinations, health screenings, and point-of-care testing. The lack of access to immunization services may lead to lower vaccination rates and vulnerabilities to infectious diseases in these communities.
Published June 27, 2025 Meagan Parrish Lead Editor post share post print email license Justin Sullivan via Getty Images Listen to the article 7 min This audio is auto-generated. Meanwhile, the decision-making production has come during a major upheaval inside the FDA. list price at $28,218 — a similar rate for other PrEP treatments.
Recent Videos Related Content Pharmacy Technicians Could Enhance Public Health by Becoming ‘Vaccine Champions’ Killian Meara October 3rd 2024 Article Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates.
Although some of these medications have additional FDA-approved uses (ie, rivaroxaban to reduce the risk of thrombotic vascular events in patients with peripheral artery disease), all 4 DOACs are approved for the treatment and prevention of venous thromboembolism and stroke prevention in nonvalvular atrial fibrillation (AFib).
In July 2025, Scientific Reports published study results suggesting that the combination of metformin and a glucagon-like peptide-1 (GLP-1) receptor agonist is more effective than other metformin combinations in protecting kidney function. 1 The study excluded patients with estimated glomerular filtration rate (eGFR) exceeding 15 mL/min/1.73
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content